trial summary · NCT07814105
[11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study
Trial record from the TrialBase DB dataset, status RECRUITING, condition Primary Aldosteronism, sponsored by Chinese University of Hong Kong. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The goal of this randomised open-label controlled study is to compare the biochemical and clinical responses following \[11C\]Metomidate-PET CT(MTO-PET) versus usual care with adrenal venous sampling as first lateralisation strategy in people with biochemically confirmed primary aldosteronism(PA). The main question it aims to answer is: what is the proportion of people who achieved complete or partial clinical success among those who underwent PA treatment?
Source record: https://clinicaltrials.gov/study/NCT07814105
Facts
| registry id | NCT07814105 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Primary Aldosteronism |
| sponsor | Chinese University of Hong Kong |
| sponsor class | OTHER |
| enrollment | 32 |
| start date | 2026-11-01 |
| primary completion | 2030-09 |
| completion | 2030-09 |
| results posted | not reported |
Conditions
- Primary Aldosteronism
Interventions
- [11C] Metomidate PETCT
- Adrenal Venous Sampling
Countries
- Hong Kong
Intervention types: PROCEDURE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.